期刊文献+

C反应蛋白与老年冠心病患者颈动脉病变及冠状动脉钙化的关系

Serum C-reactive protein is positively correlated with pathological changes of carotid artery and coronary calcification in elderly patients with coronary artery disease
下载PDF
导出
摘要 目的通过对老年冠心病患者血清C反应蛋白(CRP)检测,颈动脉内膜中层厚度的测定,冠状动脉钙化积分的测定来探讨冠心病患者颈动脉粥样硬化程度与冠状动脉病变的相关性。方法96例老年冠心病患者分别检测血浆CRP值、颈动脉超声和螺旋CT冠状动脉钙化积分,观察颈动脉内膜中层厚度(IMT)与CRP关系;不同级别颈动脉斑块与CRP的关系;以及颈动脉不同级别斑块与冠状动脉钙化积分关系。结果血清CRP随着IMT的增加而升高(P<0.05),血清CRP随着颈内动脉斑块级别的增加而升高(P<0.05)。颈动脉内膜中斑块级别越高,检出冠状动脉钙化积分值越高(P<0.05)。结论CRP不仅与冠状动脉粥样硬化程度成正比,与颈内动脉斑块的范围及严重程度也成正比。老年冠心病患者颈动脉粥样硬化程度与冠状动脉病变程度相一致。 Objective To see whether there is any correlation between C-reactive protein (CRP) and pathological changes of carotid artery and coronary calcification in elderly patients with coronary artery disease (CAD) by determination of CRP, e.arotid intima-media thickness (IMT) and coronary calcification index (CCI). Methods Serum CRP in different IMT and different plaques in the carotid artery and CCI were measured and analyzed in 96 CAD old patients. Results The higher the serum CRP was, the greater the IMT (P〈0.05), the higher the grade of the plaque in the carotid artery (P〈0.05), and the higher the CCl (P〈0.05). Conclusions Serum CRP is not only positively e.orrelated with the degree of coronary atheroselerosis but with the extent of plaques in the carotid after. The degree of carotid atheroselerosis is consistent with coronary calcification in elderly CAD patients.
出处 《老年医学与保健》 CAS 2007年第6期357-359,共3页 Geriatrics & Health Care
关键词 C反应蛋白质 冠状动脉疾病 颈动脉疾病 C-reactive protein Coronary distase Carotid artery distasts
  • 相关文献

参考文献8

  • 1Banach M, Markuszekski L, Zaslonka J, el al. The role of infection in the pathogenesis of atherosclerosis. Przegl Epidemiol, 2004, 58:671-676.
  • 2Li JJ, Fang CH. C-reaclive protein is not only an inflammalory marker but also a direct cause of cardiovascular disease. Med Hypotheses, 2004, 62: 499-506.
  • 3许竹梅,赵水平,范平.超声测量颈动脉内膜中层厚度与颈动脉斑块的关系[J].中国动脉硬化杂志,2000,8(2):165-168. 被引量:196
  • 4Koerig W. Inflammation and coronary heart disease: an overview. Cardiol Rev, 2001, 9:31-35.
  • 5Godsland IF, Eikeles RS, Feher MD, el al. Coronary calcification,homoeysteine,C-reactive protein and the metabolic syndrome in Type 2 diabetes:the Prospective Evaluation of Diabetic Ischaemic Heart Disease by Coronary Tomogrophy Study.Diabet Med, 2006. 23: 1192-1200.
  • 6Toss H, Lindaht B, Siebahn A, et al. Prognostic influence of increased fibfinogen and Creactive protein levels in unstable coronary heart disease. Circulation, 1997, 96: 4204-4210.
  • 7Ewart HKM. Rider PM, Rifai N,et al. Absence of diurnal variation of C-reactive protein levels in heallhy human subjects. Clin Chem, 2001,47: 426-430.
  • 8Haverkate F, Thompson SG, Pyke SDM, et al. Production of C-reactive protein and risk of coronary events in stable and unstable ungina. Lancet, 1997, 349: 462-466.

二级参考文献1

  • 1Skoglund C,Arterioscler Thromb Vasc Biol,1999年,19期,2422页

共引文献195

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部